WASET
	@article{(Open Science Index):https://publications.waset.org/pdf/10008811,
	  title     = {Biodistribution Studies of 177Lu-DOTATOC in Mouse Tumor Model: Possible Utilization in Adenocarcinoma Breast Cancer Treatment},
	  author    = {M. Mousavi-Daramoroudi and  H. Yousefnia and  F. Abbasi-Davani and  S. Zolghadri and  S. Kakaei},
	  country	= {},
	  institution	= {},
	  abstract     = {Despite the appropriate characteristics of 177Lu and DOTATOC, to our best knowledge, the therapeutic benefit of 177Lu-DOTATOC complex in breast cancer has not been reported until now. In this study, biodistribution of 177Lu-DOTA-TOC in mouse tumor model for evaluation of possible utilization of this complex in breast cancer treatment was investigated.177Lu was prepared with the specific activity of 2.6-3 GBq.mg-1 and radionuclidic purity higher than 99%. The radiolabeled complex was prepared in the optimized conditions with the radiochemical purity higher than 99%. The final solution was injected to the BALB/c mice with adenocarcinoma breast cancer. The biodistribution results showed major accumulation in the kidneys as the major excretion route and the somatostatin receptor-positive tissues such as pancreas compared with the other tissues. Also, significant uptake was observed in tumor even in longer time after injection. According to the results obtained in this research study, somatostatin receptors expressed in breast cancers can be targeted with DOTATOC analogues especially with 177Lu-DOTATOC as an ideal therapeutic agent.
},
	    journal   = {International Journal of Medical and Health Sciences},
	  volume    = {11},
	  number    = {12},
	  year      = {2017},
	  pages     = {700 - 704},
	  ee        = {https://publications.waset.org/pdf/10008811},
	  url   	= {https://publications.waset.org/vol/132},
	  bibsource = {https://publications.waset.org/},
	  issn  	= {eISSN: 1307-6892},
	  publisher = {World Academy of Science, Engineering and Technology},
	  index 	= {Open Science Index 132, 2017},
	}